Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/23725359/ below:

More comprehensive discussion of CRC screening associated with higher screening

Affiliations

• ¹ Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.

• PMID: 23725359
• PMCID: PMC3891849

Item in Clipboard

Observational Study

David M Mosen et al. Am J Manag Care. 2013 Apr.

• ¹ Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.

• PMID: 23725359
• PMCID: PMC3891849

Item in Clipboard

Objectives: Examine association of comprehensiveness of colorectal cancer (CRC) screening discussion by primary care physicians (PCPs) with completion of CRC screening.

Study design: Observational study in Kaiser Permanente Northwest, a group-model health maintenance organization.

Methods: A total of 883 participants overdue for CRC screening received an automated telephone call (ATC) between April and June 2009 encouraging CRC screening. Between January and March 2010, participants completed a survey on PCPs' discussion of CRC screening and patient beliefs regarding screening.

Primary outcome measure: receipt of CRC screening (assessed by electronic medical record [EMR], 9 months after ATC). Primary independent variable: comprehensiveness of CRC screening discussion by PCPs (7-item scale). Secondary independent variables: perceived benefits of screening (4-item scale assessing respondents' agreement with benefits of timely screening) and primary care utilization (EMR; 9 months after ATC). The independent association of variables with CRC screening was assessed with logistic regression.

Results: Average scores for comprehensiveness of CRC discussion and perceived benefits were 0.4 (range 0-1) and 4.0 (range 1-5), respectively. A total of 28.2% (n = 249) completed screening, 84% of whom had survey assessments after their screening date. Of screeners, 95.2% completed the fecal immunochemical test. More comprehensive discussion of CRC screening was associated with increased screening (odds ratio [OR] = 1.51, 95% confidence interval [CI] = 1.03-2.21). Higher perceived benefits (OR = 1.46, 95% CI = 1.13-1.90) and 1 or more PCP visits (OR = 5.82, 95% CI = 3.87-8.74) were also associated with increased screening.

Conclusions: More comprehensive discussion of CRC screening was independently associated with increased CRC screening. Primary care utilization was even more strongly associated with CRC screening, irrespective of discussion of CRC screening.

PubMed Disclaimer

Patient Survey Process Flow

Patient Survey Process Flow

Patient Survey Process Flow

• Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening?

  Baxter NN, Sutradhar R, Li Q, Daly C, Honein-AbouHaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L, Rabeneck L. Baxter NN, et al. Am J Gastroenterol. 2017 Apr;112(4):622-632. doi: 10.1038/ajg.2017.4. Epub 2017 Feb 28. Am J Gastroenterol. 2017. PMID: 28244494

• A national survey of primary care physicians' colorectal cancer screening recommendations and practices.

  Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. Klabunde CN, et al. Prev Med. 2003 Mar;36(3):352-62. doi: 10.1016/s0091-7435(02)00066-x. Prev Med. 2003. PMID: 12634026

• Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.

  Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA. Halm EA, et al. J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8. J Gen Intern Med. 2016. PMID: 27279097 Free PMC article.

• Automated telephone calls improved completion of fecal occult blood testing.

  Mosen DM, Feldstein AC, Perrin N, Rosales AG, Smith DH, Liles EG, Schneider JL, Lafata JE, Myers RE, Kositch M, Hickey T, Glasgow RE. Mosen DM, et al. Med Care. 2010 Jul;48(7):604-10. doi: 10.1097/MLR.0b013e3181dbdce7. Med Care. 2010. PMID: 20508529 Free PMC article. Clinical Trial.

• Predictors of colorectal cancer screening variation among primary-care providers and clinics.

  Weiss JM, Smith MA, Pickhardt PJ, Kraft SA, Flood GE, Kim DH, Strutz E, Pfau PR. Weiss JM, et al. Am J Gastroenterol. 2013 Jul;108(7):1159-67. doi: 10.1038/ajg.2013.127. Epub 2013 May 14. Am J Gastroenterol. 2013. PMID: 23670114 Free PMC article.

• Screening for colorectal cancer: the role of the primary care physician.

  Triantafillidis JK, Vagianos C, Gikas A, Korontzi M, Papalois A. Triantafillidis JK, et al. Eur J Gastroenterol Hepatol. 2017 Jan;29(1):e1-e7. doi: 10.1097/MEG.0000000000000759. Eur J Gastroenterol Hepatol. 2017. PMID: 27676092 Free PMC article. Review.

• The Effectiveness of a Physician-Only and Physician-Patient Intervention on Colorectal Cancer Screening Discussions Between Providers and African American and Latino Patients.

  Dolan NC, Ramirez-Zohfeld V, Rademaker AW, Ferreira MR, Galanter WL, Radosta J, Eder MM, Cameron KA. Dolan NC, et al. J Gen Intern Med. 2015 Dec;30(12):1780-7. doi: 10.1007/s11606-015-3381-8. Epub 2015 May 19. J Gen Intern Med. 2015. PMID: 25986137 Free PMC article. Clinical Trial.

• Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review.

  Sosa E, D'Souza G, Akhtar A, Sur M, Love K, Duffels J, Raz DJ, Kim JY, Sun V, Erhunmwunsee L. Sosa E, et al. CA Cancer J Clin. 2021 Jul;71(4):299-314. doi: 10.3322/caac.21671. Epub 2021 May 20. CA Cancer J Clin. 2021. PMID: 34015860 Free PMC article.

• Epigenetic Biomarkers in Colorectal Cancer.

  Verma M, Kumar V. Verma M, et al. Mol Diagn Ther. 2017 Apr;21(2):153-165. doi: 10.1007/s40291-016-0244-x. Mol Diagn Ther. 2017. PMID: 27878475 Review.

• Predicting Colonoscopy Screening Behavior and Future Screening Intentions for African Americans Older than 50 Years.

  Klasko-Foster LB, Jandorf LM, Erwin DO, Kiviniemi MT. Klasko-Foster LB, et al. Behav Med. 2019 Jul-Sep;45(3):221-230. doi: 10.1080/08964289.2018.1510365. Epub 2018 Nov 14. Behav Med. 2019. PMID: 30427773 Free PMC article.

1. 1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics, 2004. CA Cancer J Clin. 2004 Jan;54(1):8–29. - PubMed
2. 1. American Cancer Society. What are the key statistics for colorectal cancer? Available at: www.cancer.org/.
3. 1. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993 Aug 18;85(16):1311–1318. - PubMed
4. 1. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000 Nov 30;343(22):1603–1607. - PubMed
5. 1. Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993 Mar 20;341(8847):736–740. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3